CNTX
Price
$0.61
Change
-$0.02 (-3.17%)
Updated
Jun 16, 12:41 PM (EDT)
Capitalization
56.46M
51 days until earnings call
SLN
Price
$5.28
Change
-$0.05 (-0.94%)
Updated
Jun 16, 01:42 PM (EDT)
Capitalization
212.54M
Interact to see
Advertisement

CNTX vs SLN

Header iconCNTX vs SLN Comparison
Open Charts CNTX vs SLNBanner chart's image
Context Therapeutics
Price$0.61
Change-$0.02 (-3.17%)
Volume$2.5K
Capitalization56.46M
Silence Therapeutics
Price$5.28
Change-$0.05 (-0.94%)
Volume$102
Capitalization212.54M
CNTX vs SLN Comparison Chart
Loading...
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTX vs. SLN commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a Buy and SLN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (CNTX: $0.63 vs. SLN: $5.33)
Brand notoriety: CNTX and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 78% vs. SLN: 37%
Market capitalization -- CNTX: $56.46M vs. SLN: $212.54M
CNTX [@Biotechnology] is valued at $56.46M. SLN’s [@Biotechnology] market capitalization is $212.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $356.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, SLN is a better buy in the long-term than CNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 5 TA indicator(s) are bullish while SLN’s TA Score has 3 bullish TA indicator(s).

  • CNTX’s TA Score: 5 bullish, 4 bearish.
  • SLN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CNTX is a better buy in the short-term than SLN.

Price Growth

CNTX (@Biotechnology) experienced а -5.23% price change this week, while SLN (@Biotechnology) price change was -2.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.26%. For the same industry, the average monthly price growth was +9.99%, and the average quarterly price growth was +8.72%.

Reported Earning Dates

CNTX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-2.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLN($213M) has a higher market cap than CNTX($56.5M). SLN YTD gains are higher at: -22.529 vs. CNTX (-40.057). CNTX has higher annual earnings (EBITDA): -31.62M vs. SLN (-71.65M). SLN has more cash in the bank: 137M vs. CNTX (89.4M). SLN has less debt than CNTX: SLN (60K) vs CNTX (194K). SLN has higher revenues than CNTX: SLN (27.7M) vs CNTX (0).
CNTXSLNCNTX / SLN
Capitalization56.5M213M27%
EBITDA-31.62M-71.65M44%
Gain YTD-40.057-22.529178%
P/E RatioN/AN/A-
Revenue027.7M-
Total Cash89.4M137M65%
Total Debt194K60K323%
TECHNICAL ANALYSIS
Technical Analysis
CNTXSLN
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 26 days ago
87%
Bullish Trend 5 days ago
89%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLPPX9.90-0.11
-1.10%
LDR Real Estate Value Opportunity P
BBTLX14.90-0.19
-1.26%
Bridge Builder Tax Managed Large Cap
THPGX102.65-1.46
-1.40%
Thompson LargeCap
GMAYX22.21-0.37
-1.64%
GMO Small Cap Quality I
BMSTX14.13-0.24
-1.67%
MFS Blended Research Mid Cap Eq R3

CNTX and

Correlation & Price change

A.I.dvisor tells us that CNTX and NRIX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and NRIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
-3.56%
NRIX - CNTX
29%
Poorly correlated
-0.25%
IPSC - CNTX
29%
Poorly correlated
-4.10%
RXRX - CNTX
29%
Poorly correlated
-4.84%
OBIO - CNTX
28%
Poorly correlated
-2.22%
SLN - CNTX
28%
Poorly correlated
-4.57%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
-4.57%
CLLS - SLN
43%
Loosely correlated
-2.69%
NGNE - SLN
38%
Loosely correlated
-3.14%
IDYA - SLN
35%
Loosely correlated
-0.45%
GBIO - SLN
34%
Loosely correlated
-3.63%
ANNX - SLN
34%
Loosely correlated
-8.12%
More